Relative survival by stage at diagnosis (lung cancer)
5311
2700
4
This measure presents national survival by stage at diagnosis data for lung cancer in Australia using data sources that are routinely accessible to all cancer registries.
Relative survival by stage at diagnosis (melanoma)
5316
2700
4
This measure presents national survival by stage at diagnosis data for melanoma of the skin in Australia using data sources that are routinely accessible to all cancer registrie
Relative survival by stage at diagnosis (prostate cancer)
5321
2700
4
This measure presents national survival by stage at diagnosis data for prostate cancer in Australia using data sources that are routinely accessible to all cancer registries.
In Australia, the prevalence of chronic hepatitis B is approximately 0.9% and hepatitis C is approximately 0.05% of the population,5 with Aboriginal and Torres Strait
This measure provides data on cancer incidence for Aboriginal and Torres Strait Islander peoples sourced from New South Wales, Queensland, Western Australia and the Northern Ter
